151 related articles for article (PubMed ID: 29207190)
1. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer.
Chen S; Nimick M; Cridge AG; Hawkins BC; Rosengren RJ
Int J Oncol; 2018 Feb; 52(2):579-588. PubMed ID: 29207190
[TBL] [Abstract][Full Text] [Related]
2. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
Megna BW; Carney PR; Depke MG; Nukaya M; McNally J; Larsen L; Rosengren RJ; Kennedy GD
J Surg Res; 2017 Jun; 213():16-24. PubMed ID: 28601309
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of curcumin derivatives in ALK positive non-small cell lung cancer.
Bland AR; Bower RL; Nimick M; Hawkins BC; Rosengren RJ; Ashton JC
Eur J Pharmacol; 2019 Dec; 865():172749. PubMed ID: 31654622
[TBL] [Abstract][Full Text] [Related]
4. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
5. Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo.
Mapoung S; Suzuki S; Fuji S; Naiki-Ito A; Kato H; Yodkeeree S; Ovatlarnporn C; Takahashi S; Limtrakul Dejkriengkraikul P
Cancer Sci; 2019 Feb; 110(2):596-607. PubMed ID: 30499149
[TBL] [Abstract][Full Text] [Related]
6. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
7. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
8. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
[TBL] [Abstract][Full Text] [Related]
9. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and apoptosis-inducing activity of curcumin against human gallbladder adenocarcinoma cells.
Ono M; Higuchi T; Takeshima M; Chen C; Nakano S
Anticancer Res; 2013 May; 33(5):1861-6. PubMed ID: 23645731
[TBL] [Abstract][Full Text] [Related]
11. Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells.
Zhang X; Chen M; Zou P; Kanchana K; Weng Q; Chen W; Zhong P; Ji J; Zhou H; He L; Liang G
BMC Cancer; 2015 Nov; 15():866. PubMed ID: 26546056
[TBL] [Abstract][Full Text] [Related]
12. Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro.
Wu J; Cai Z; Wei X; Chen M; Ying S; Shi L; Xu RA; He F; Liang G; Zhang X
Biomed Res Int; 2015; 2015():504529. PubMed ID: 25977922
[TBL] [Abstract][Full Text] [Related]
13. Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.
Schwertheim S; Wein F; Lennartz K; Worm K; Schmid KW; Sheu-Grabellus SY
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1143-1154. PubMed ID: 28265769
[TBL] [Abstract][Full Text] [Related]
14. Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer Activity.
Schmitt F; Subramaniam D; Anant S; Padhye S; Begemann G; Schobert R; Biersack B
ChemMedChem; 2018 Jun; 13(11):1115-1123. PubMed ID: 29570947
[TBL] [Abstract][Full Text] [Related]
15. MC37, a new mono-carbonyl curcumin analog, induces G2/M cell cycle arrest and mitochondria-mediated apoptosis in human colorectal cancer cells.
Liang B; Liu Z; Cao Y; Zhu C; Zuo Y; Huang L; Wen G; Shang N; Chen Y; Yue X; Du J; Li B; Zhou B; Bu X
Eur J Pharmacol; 2017 Feb; 796():139-148. PubMed ID: 28024945
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
[TBL] [Abstract][Full Text] [Related]
17. Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation.
Yang C; Ma X; Wang Z; Zeng X; Hu Z; Ye Z; Shen G
Drug Des Devel Ther; 2017; 11():431-439. PubMed ID: 28243065
[TBL] [Abstract][Full Text] [Related]
18. Maspin Enhances the Anticancer Activity of Curcumin in Hormone-refractory Prostate Cancer Cells.
Cheng WL; Huang CY; Tai CJ; Chang YJ; Hung CS
Anticancer Res; 2018 Feb; 38(2):863-870. PubMed ID: 29374713
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.
Somers-Edgar TJ; Taurin S; Larsen L; Chandramouli A; Nelson MA; Rosengren RJ
Invest New Drugs; 2011 Feb; 29(1):87-97. PubMed ID: 19816657
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]